Our Board

The Lung Foundation Australia Board consists of ten directors who volunteer their expertise and time to help improve lung health and reduce the impact of lung disease for all Australians. Led by Professor Lucy Morgan, our Board delegates responsibility for day-to-day operations to our CEO who, together with our Executive Team, is accountable to the Board.

Professor Lucy Morgan – Chair Board Member since September 2019

Professor Lucy Morgan is a Respiratory Physician in Sydney with clinical roles at Concord Hospital, Nepean Hospital and Macquarie University Private Hospital. She has had a long history with Lung Foundation Australia having been awarded the Lung Foundation Australia Boehringer Ingelheim COPD Fellowship in 1998, chaired the Lung Foundation Australia Palliative and Supportive Care Committee and the Respiratory Infectious Diseases Committee, been a member of the Australasian Lung Cancer Trials Group and COPD-X Committee, Lung Foundation Australia Clinical Council and more recently, Lead Clinician of Lung Foundation Australia’s Australian Bronchiectasis Registry. She is a passionate advocate for equity of access to benchmark clinical care for all Australians with lung disease and for gender equity in research and clinical leadership.

Mr Andrew Churchill – Deputy Chair Board Member since March 2010

Mr Andrew Churchill is an experienced executive and director with a strong business background in the professional services, telecommunications and information technology sectors. Mr Churchill has significant experience in strategy development and implementation, paired with strong financial management skills. He has provided a range of business management, mentoring, coaching and advisory services through his management services firm Churchill Associates, and has previously held CEO and Board positions in both private and public companies.

Professor Christine Jenkins AM Board Member since September 2012

Professor Christine Jenkins AM has a strong commitment to respiratory practice and clinical research, particularly in the management of asthma and Chronic Obstructive Pulmonary Disease (COPD). She is the Professor of Respiratory Medicine at the University of New South Wales Sydney and heads the Respiratory Group at The George Institute for Global Health, Sydney, Australia. She is also Clinical Professor at Concord Clinical School, the University of Sydney.  Professor Jenkins has played major roles in advocacy and leadership for lung health in Australia, has over 250 publications including three books, and has contributed to respiratory guidelines in Australia and internationally. She has made significant contributions to the community sector through senior leadership positions for government, health professional and not-for-profit organisations. She was awarded Member, Order of Australia in 2002 for Services to Respiratory Medicine, was President of the Thoracic Society of Australia and New Zealand from 2007-2009, and Chair of Lung Foundation Australia from 2016 – 2021.

Professor Martin Phillips Board Member since September 2012

Professor Phillips is a Respiratory Physician practising at Macquarie University Hospital and is an Hon Clinical Professor at Macquarie University. His clinical interests are in Interventional Pulmonology, lung cancer, asthma, emphysema and Interstitial Lung Disease . He has served on several committees for the Royal Australasian College of Physicians and the Thoracic Society of Australia and New Zealand, and chaired Special Interest Groups in Interventional Pulmonology and Lung Cancer. He was previously a Clinical Professor at the University of Western Australia and Consultant Respiratory Physician at Sir Charles Gairdner Hospital in Perth, where he had been Head of the Department of Respiratory Medicine and Director of Lung Cancer and Interventional Pulmonology Services.

Dr David Michail Board Member since March 2013

Doctor David Michail is a Consultant Respiratory and Sleep Physician working as a Senior Visiting Medical Officer at Westmead Hospital and with specialist services. He is the Clinical Lead of the Western Sydney Multidisciplinary Lung Cancer Group and is the Director of the Pulmonary Hypertension Service at Westmead Hospital, as well as a member of the Clinical Trials Program of the Ludwig Engel Centre for Respiratory Research. In addition to his roles in lung cancer and Pulmonary Hypertension, he has a key interest in ambulatory models of care for sleep disorders and their management in primary care. Doctor Michail also chairs Lung Foundation Australia’s Pulmonary Arterial Hypertension Committee.


Professor Sarath Ranganathan Board Member since April 2014

Professor Sarath Ranganathan is Stevenson Chair, Head of Department of Paediatrics and Academic Director for Clinical Education Strategy and Risk at the University of Melbourne. He is also a paediatric respiratory physician and ex-Director of Respiratory and Sleep Medicine at the Royal Children’s Hospital and Head of Respiratory Diseases Research at the Murdoch Children’s Research Institute, Melbourne. Sarath is an elected Fellow of the American Thoracic Society and the Thoracic Society of Australia and New Zealand.  Professor Ranganathan ‘s areas of expertise include Cystic Fibrosis, paediatric asthma, allergy, paediatric bronchoscopy, tuberculosis and lower respiratory tract infection. He has published more than 300 peer-reviewed papers and raised over $50 million in research funding.

Angela Ratcliffe March 2024

Ms Angela Ratcliffe AICD Board Member since December 2018

Ms Angela Ratcliffe has over 30 years business leadership experience working in Consumer, Industrial and Healthcare Sectors in Australia, UK and Asia. Her experience includes creating new business models, building high performance teams and successfully leading through, crisis management, change and uncertainty. In her senior leadership roles she has been a member of the ANZ Executive Leadership Teams for multinationals 3M, Staples and Philips and in her most recent role, as Leader of Connected Health Care APAC, was a member of the Philips APAC Executive Leadership Team. Angela is the Principal of Inspiring Futures, dedicated to helping executives reach their full potential. Ms Ratcliffe is an experienced and qualified director in both not-for-profit and commercial sectors, is a qualified executive coach and Six Sigma Black Belt. Angela brings to the Board specialisation in strategy, risk, marketing, general management, digital connectivity and customer experience. She is the Chair of the LFA Digital Evolution Sub Committee that provides oversight and governance for the LFA digital journey. Angela is passionate about equity in health care, efficiency within health systems and lung health. Driven by her own family experience Angela is keen to help improve the lives of those with lung disease and support both patients and families through their health journey.

Professor Paul Reynolds Board Member since September 2019

Medical School at the University of Adelaide, then Physician Training in Respiratory and Sleep Medicine at the Royal Adelaide Hospital (RAH) in 1992. He then undertook a PhD in the molecular biology of airways disease at The Hanson Institute/RAH/University of Adelaide, then a five-year Post-Doc / Research Assistant Professor position in the Division of Human Gene Therapy, University of Alabama in Birmingham. He returned to the RAH in 1992 to take up a position as Consultant Physician in the Department of Thoracic Medicine, and Director of the Lung Research Laboratory. Professor Reynolds has over 150 peer-reviewed publications. He also holds an Adjunct Professor position in University of South Australia and is a member of the Centre for Cancer Biology. He Chairs the RAH Research Committee and has overseen the distribution of many millions of dollars in funding to the RAH Research Community. Other local leadership roles have included Chair of the Medical Staff Society and Vice-President of South Australian Salaried Medical Officers Association. Professor Reynolds is currently Medical Lead of the Heart and Lung Program of the Central Adelaide Local Health Network (overseeing Thoracic and Sleep Medicine, Cardiology and Cardiothoracic Surgery), and is a former President of the Thoracic Society of Australia and New Zealand and winner of the Society Medal.

Ms Melissa Le Mesurier Board Member since September 2019

With original training as a journalist, Ms Melissa Le Mesurier has 25 years experience as a senior corporate affairs executive with blue-chip organisations such as Medibank, Kraft/Cadbury, Foster’s Group and Australian Airlines. She is currently the Principal of MLM Consulting which advises executives and boards on strategy, reputation, cultural change and communications. Both professionally and personally, Ms Le Mesurier is passionate about medical research, consumer engagement and patient empowerment – something sparked when her (now adult) son was diagnosed with Cystic Fibrosis (CF) in 1996. She is a Graduate of the Australian Institute of Company Directors and a member of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Consumer Advisory Panel. She was previously a member of the Alfred Hospital’s CF Consumer Advisory Panel and founding Chair of the Royal Children’s Hospital Cystic Fibrosis Research Trust (1999-2009) which has raised more than $3 million for research and funded about 20 clinical fellows.

Robert Estcourt AM Board Member since April 2023

Chair of the Board of Directors of the Woolcock Institute of Medical Research and member of its Finance Committee,member of the RANZCO Investment Committee, member Australian Sleep Association Finance and Audit Committee, Director of the Lung Foundation and a member of their Finance Committee and their Investment Advisory Committee, Director Radio 2RPH and Chair of their Finance & Investment Advisory Committees, Consultant AA Solutions. Rob is the newest Director of the Lung Foundation Australia Board of Directors, having joined in April 2023.